RxDoctor Payments DataLook up a doctor →

Scott Tannehill, MD

Radiation Oncology · Scottsdale, AZNPI 1902897440

Payments from drug & device makers

$7,613in general payments, 2019–2025

Across 282 payments — averaging $27.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Visionrt, Inc.$811
  • Pfizer$440
  • Johnson & Johnson$385
  • AstraZeneca$359
  • Merck$326
  • Bayer$311
  • plus $5K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Visionrt, Inc.9$811
Pfizer19$440
Johnson & Johnson(2 entities)19$385
AstraZeneca16$359
Merck16$326
Bayer16$311
Regeneron Healthcare Solutions, Inc.6$284
Novartis14$274
Novocure Inc.6$253
Elekta, Inc.2$245
Daiichi Sankyo Inc.9$238
AbbVie12$230
Seagen Inc.8$208
Myriad Genetic Laboratories, Inc.6$197
Takeda Pharmaceuticals U.S.A., Inc.7$183
Telix Pharmaceuticals3$179
Tactile Systems Technology Inc3$156
Springworks Therapeutics, Inc.6$141
Progenics Pharmaceuticals, Inc.6$138
Advanced Accelerator Applications7$137
E.r. Squibb & Sons, L.L.C.7$128
Eisai Inc.5$113
Sumitomo Pharma America, Inc.5$113
Astellas Pharma US Inc5$105
Gilead(2 entities)5$103
Tersera Therapeutics LLC3$101
Boston Scientific6$97
Medtronic1$94
GE HealthCare3$93
Incyte Corporation4$92
Blue Earth Diagnostics3$67
AVEO Pharmaceuticals, Inc.3$63
Sun Pharmaceutical Industries Inc.2$62
Ipsen Biopharmaceuticals, Inc3$61
Puma Biotechnology, Inc.3$61
Sobi, Inc2$59
Lilly USA, LLC3$57
Genmab U.S., Inc.2$54
EMD Serono, Inc.2$53
Iovance Biotherapeutics, Inc.2$46
Siemens Medical Solutions USA, Inc.1$41
Adaptive Biotechnologies Corporation2$37
Intuitive Surgical1$35
Tempus AI, Inc2$34
Dendreon Pharmaceuticals LLC1$33
Aurobindo Pharma USA, Inc.2$33
Mylan Institutional Inc.1$30
Pharmacyclics LLC, An Abbvie Company1$26
GSK1$25
ADC Therapeutics America, Inc.1$25
Teleflex LLC1$23
Sanofi1$21
Acrotech Biopharma Inc.1$19
Bioprotect Medical, Inc.1$19
Bristol Myers Squibb1$18
Mirati Therapeutics, Inc.1$17
Verity Pharmaceuticals Inc.1$15
Isoray, Inc1$13
Karyopharm Therapeutics Inc.1$13
Cardinal Health 414 LLC1$13

How this compares

$7,613 in reported general payments places this provider in the 70th percentile of 138 radiation oncology providers in Arizona.

See all radiation oncology providers in Arizona →

Medicare billing

Part B allowed, 2024
$674,260
Medicare patients
225
Services billed
3,233

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Scottsdale

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →